Home/Filings/4/0000930413-18-000098
4//SEC Filing

WEINER BARRY W 4

Accession 0000930413-18-000098

CIK 0000316253other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:43 PM ET

Size

10.3 KB

Accession

0000930413-18-000098

Insider Transaction Report

Form 4
Period: 2018-01-17
WEINER BARRY W
DirectorPres, CFO & Principal Acct Off
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-17$2.88/sh+30,802$88,7101,313,111 total
  • Sale

    Common Stock

    2018-01-17$7.75/sh11,000$85,2501,302,111 total
  • Tax Payment

    Common Stock

    2018-01-17$7.75/sh11,626$90,1021,290,485 total
  • Exercise/Conversion

    Stock Option (to aquire common stock)

    2018-01-1730,802184,794 total
    Exercise: $2.88From: 2014-01-17Exp: 2018-01-17Common Stock (30,802 underlying)
Footnotes (3)
  • [F1]Represents shares sold to satisfy reporting person's tax obligations.
  • [F2]Represents shares withheld by the company to cover the exercise price of the Stock Options.
  • [F3]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0000901503

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:43 PM ET
Size
10.3 KB